Search results
These Are the 2 Most Common Symptoms of the New FLiRT COVID Variant Doctors Are Seeing Right Now
Parade via Yahoo News· 4 days ago"We are not in flu season, so if you are experiencing flu-like symptoms, it may be a sign that you...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 6 days agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 20 hours agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Covid inquiry: What is it investigating and how does it work?
BBC via Yahoo News· 2 hours agoKirsten Heaven, counsel for the Covid-19 Bereaved Families Cymru: said there had been a "passive,...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 4 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
AstraZeneca pulls its COVID-19 vaccine from the European market
The Nashua Telegraph· 5 days agoSIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 1 day agos (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi (SNY). The deal signed with Sanofi on May 10, 2024, relates ...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 15 hours agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
AstraZeneca withdraws Covid-19 vaccine, citing plethora of other shots and low demand
ABC Action News Tampa Bay· 6 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 12 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...